Drug Profile
Research programme: hepatitis B virus therapeutics - Benitec
Alternative Names: BB-101; BB-102; BB-103; BB-HB-331; Hepbarna; Hepbarna™ programmeLatest Information Update: 28 Mar 2022
Price :
$50
*
At a glance
- Originator Benitec Biopharma - Biomics Biotechnologies (JV)
- Class Small interfering RNA
- Mechanism of Action DNA-directed RNA polymerase inhibitors; RNA interference
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Hepatitis B